Circulating miR-122 Is a Predictor for Virological Response in CHB Patients With High Viral Load Treated With Nucleos(t)ide Analogs

Chronic hepatitis B (CHB) infection remains worldwide health problem. Antiviral treatment options for CHB patients include nucleos(t)ide analogs (NAs) and interferon. Most of the current biomarkers for predicting treatment response are virus-dependent. MicroRNA-122 is the most abundant liver-specifi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Genet
Hlavní autoři: Wu, Yin, Gao, Chang, Cai, Shaohang, Xia, Muye, Liao, Guichan, Zhang, Xiaoyong, Peng, Jie
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2019
Témata:
Genetics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6440383/
https://ncbi.nlm.nih.gov/pubmed/30967899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2019.00243
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky